Regorafenib
Brand name: Stivarga
Regorafenib comes in 2 pill versions in our database, in 1 strength, from 2 manufacturers. Check the imprint to tell them apart.
Regorafenib pill images
40 mg 2 pills
What is Regorafenib used for?
Regorafenib is used for colorectal cancer, hepatocellular carcinoma and gastrointestinal stromal tumors.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Colorectal Cancer
STIVARGA is indicated for the treatment of adult patients with metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type, an anti-EGFR therapy.
Gastrointestinal Stromal Tumors
STIVARGA is indicated for the treatment of adult patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate.
Hepatocellular Carcinoma
STIVARGA is indicated for the treatment of adult patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.
From the FDA-approved label on DailyMed (published Feb 18, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.